[go: up one dir, main page]

ES2055719T3 - Derivados de desmanosil-teicoplanina. - Google Patents

Derivados de desmanosil-teicoplanina.

Info

Publication number
ES2055719T3
ES2055719T3 ES88110195T ES88110195T ES2055719T3 ES 2055719 T3 ES2055719 T3 ES 2055719T3 ES 88110195 T ES88110195 T ES 88110195T ES 88110195 T ES88110195 T ES 88110195T ES 2055719 T3 ES2055719 T3 ES 2055719T3
Authority
ES
Spain
Prior art keywords
derivatives
desmanosil
teicoplanine
nrrl
mannosylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88110195T
Other languages
English (en)
Inventor
Angelo Borghi
Piero Antonini
Giancarlo Lancini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of ES2055719T3 publication Critical patent/ES2055719T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/51—Streptomyces candidus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EL OBJETO DE ESTE INVENTO SON LOS DERIVADOS TEICOPLAIN DE-MANNOSIT QUE PUEDEN SER OBTENIDOS EN BUENA PRODUCCION POR TRANSFORMACION MICROBIOLOGICA CON CULTIVOS DE NOCARDIA ORIENTALES NRRL 2450 O STREPTOWYES CANDIDUS NRRL 3228.
ES88110195T 1987-07-03 1988-06-27 Derivados de desmanosil-teicoplanina. Expired - Lifetime ES2055719T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878715735A GB8715735D0 (en) 1987-07-03 1987-07-03 De-mannosyl teicoplanin derivatives

Publications (1)

Publication Number Publication Date
ES2055719T3 true ES2055719T3 (es) 1994-09-01

Family

ID=10620077

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88110195T Expired - Lifetime ES2055719T3 (es) 1987-07-03 1988-06-27 Derivados de desmanosil-teicoplanina.

Country Status (13)

Country Link
US (1) US5064811A (es)
EP (1) EP0301247B1 (es)
JP (1) JPH0819155B2 (es)
KR (1) KR890002214A (es)
AT (1) ATE90731T1 (es)
CA (1) CA1334655C (es)
DE (1) DE3881775T2 (es)
DK (1) DK357488A (es)
ES (1) ES2055719T3 (es)
GB (1) GB8715735D0 (es)
HU (1) HU200488B (es)
IL (1) IL86895A (es)
ZA (1) ZA884577B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135857A (en) * 1987-07-03 1992-08-04 Gruppo Lepetit S.P.A. Process for the preparation of de-mannosyl teicoplanin derivatives
ATE135369T1 (de) * 1988-12-27 1996-03-15 Lepetit Spa Chemisches verfahren zur herstellung des antibiotikums l 17392 (deglukoteicoplanin) und dessen salze
US5500410A (en) * 1989-03-29 1996-03-19 Gruppo Lepetit S.P.A. Substituted alkylamide derivatives of teicoplanin
US5185320A (en) * 1989-04-03 1993-02-09 Gruppo Lepetit S.P.A. O56 -alkyl derivatives of aglycone and pseudo aglycones of teicoplanin
DE69127645T2 (de) 1990-03-28 1998-02-12 Lepetit Spa Verfahren zur Herstellung von Mannosylteicoplaninderivaten und Mannosylteicoplaninaglykon
JPH06503306A (ja) * 1990-12-05 1994-04-14 グルポ・レペチツト・エス・ピー・エイ テイコプラニン抗生物質の３８−デカルボキシ−３８−ヒドロキシメチル誘導体およびそれらの製造方法
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
IL122151A (en) * 1995-07-05 2001-08-26 Lepetit Spa Purification of dalbaheptide antibiotics by isoelectric focusing
US5638609A (en) * 1995-11-13 1997-06-17 Manufacturing And Technology Conversion International, Inc. Process and apparatus for drying and heating
DE69708293T2 (de) 1996-04-23 2002-05-02 Biosearch Italia S.P.A., Gerenzano Chemisches Verfahren zur Herstellung von Amidderivaten von A 40926 Antibiotikum
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US20050004011A1 (en) * 2002-11-18 2005-01-06 Marco Cavaleri Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
JP6117701B2 (ja) 2011-10-25 2017-04-19 株式会社パイロットコーポレーション 可逆熱変色性組成物
CN106459637B (zh) 2014-04-24 2019-10-01 株式会社百乐 可逆热变色性印章用墨液组合物及印章
CN107175968A (zh) * 2017-07-12 2017-09-19 重庆工业职业技术学院 一种大学生思想政治教育智能教学系统
EP3702419B1 (en) 2017-10-23 2023-09-20 Kabushiki Kaisha Pilot Corporation (also trading as Pilot Corporation) Reversible thermochromic aqueous ink composition and writing instrument using same
WO2020066650A1 (ja) 2018-09-25 2020-04-02 パイロットインキ株式会社 可逆熱変色性複合繊維
JPWO2024005057A1 (es) 2022-06-29 2024-01-04

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics
JPS5830037A (ja) * 1981-08-18 1983-02-22 Toshiba Corp 陰極線管の製造装置
FI73697C (fi) * 1982-06-08 1987-11-09 Lepetit Spa Foerfarande foer framstaellning av individuella faktorer 1, 2, 3, 4 och 5 av teikomysin a2.
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
AU579120B2 (en) * 1983-12-16 1988-11-17 Gruppo Lepetit S.P.A. Chemical process for preparing antibiotic L 17392 (deglucoteicoplanin) and its salts
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609

Also Published As

Publication number Publication date
EP0301247B1 (en) 1993-06-16
HU200488B (en) 1990-06-28
DK357488A (da) 1989-01-04
KR890002214A (ko) 1989-04-10
US5064811A (en) 1991-11-12
EP0301247A2 (en) 1989-02-01
JPH0819155B2 (ja) 1996-02-28
GB8715735D0 (en) 1987-08-12
JPS6429398A (en) 1989-01-31
DK357488D0 (da) 1988-06-29
IL86895A (en) 1993-04-04
DE3881775D1 (de) 1993-07-22
CA1334655C (en) 1995-03-07
HUT49379A (en) 1989-09-28
EP0301247A3 (en) 1990-07-11
DE3881775T2 (de) 1994-01-05
ZA884577B (en) 1989-04-26
ATE90731T1 (de) 1993-07-15
IL86895A0 (en) 1988-11-30

Similar Documents

Publication Publication Date Title
ES2055719T3 (es) Derivados de desmanosil-teicoplanina.
WO1989006649A3 (en) Antibacterial agents
HK61196A (en) Bipolar transistor arrangement with distortion compensation
NO872811D0 (no) Antibiotikum a 42867 og addisjonssalter derav samt fremgangsmaate for deres fremstilling.
DK53488A (da) Cytochrom-p-450-enzymer samt fremgangsmaade til fremstilling heraf
DE69127645D1 (de) Verfahren zur Herstellung von Mannosylteicoplaninderivaten und Mannosylteicoplaninaglykon
HK164696A (en) Bipolar transistor amplifier
DK0424051T3 (da) Glycopeptid-antibiotika
NZ220996A (en) 1,2,3 thiadiazole-4-thiolates

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301247

Country of ref document: ES